Temozolomide in the treatment of recurrent malignant glioma in Chinese patients

Hong Kong Medical Journal

Volumn 11, Issue 6, 2005, Pages 452-456

  Chan, D T M ^a   Poon, W S ^a   Chan, Y L ^a   Ng, H K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Astrocytoma; Brain neoplasms; Disease free survival; Glioblastoma; Neoplasm recurrence

Indexed keywords

GADOLINIUM; TEMOZOLOMIDE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHINESE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DRUG RESPONSE; DRUG SAFETY; FEMALE; GLIOBLASTOMA; HUMAN; MALE; MONITORING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PATIENT; POPULATION RESEARCH; RECURRENT DISEASE; TISSUE SECTION; TUMOR GROWTH; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; DACARBAZINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOMA; HONG KONG; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE;

EID: 30944434401     PISSN: 10242708     EISSN: 10242708     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Quigley MR, Maroon JC. The relationship between survival and the extent of the resection in patients with supratentorial malignant glioma. Neurosurgery 1991;29:385-9.
2. Daneyemez M, Grezen F, Canakci Z, Kahraman S. Radical surgery and reoperation in supratentorial malignant glial tumors. Minim Invasive Neurosurg 1998;41:209-13.
3. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-9.
4. Walker MD, Alexander E Jr, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic glioma. A cooperative clinical trial. J Neurosurg 1978;49:333-43.
5. Yung WK, Albright RE, Olson J, et al. A phase II study of temozolomide vs procarbazine in patient with glioblastoma multiforme at first relapse. Br J Cancer 2000;83:588-93.
6. Yung WK, Prados MD, Yaya-Tur R, et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 1999;17:2762-71.